Does DEGARELIX Cause Neoplasm malignant? 8 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Neoplasm malignant have been filed in association with DEGARELIX (FIRMAGON). This represents 0.2% of all adverse event reports for DEGARELIX.
8
Reports of Neoplasm malignant with DEGARELIX
0.2%
of all DEGARELIX reports
2
Deaths
3
Hospitalizations
How Dangerous Is Neoplasm malignant From DEGARELIX?
Of the 8 reports, 2 (25.0%) resulted in death, 3 (37.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEGARELIX. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does DEGARELIX Cause?
Injection site pain (296)
Injection site erythema (246)
Hot flush (199)
Fatigue (195)
Injection site swelling (183)
Product storage error (177)
Pyrexia (170)
Off label use (128)
Asthenia (123)
Death (120)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which DEGARELIX Alternatives Have Lower Neoplasm malignant Risk?
DEGARELIX vs DELAFLOXACIN MEGLUMINE
DEGARELIX vs DELAMANID
DEGARELIX vs DELANDISTROGENE MOXEPARVOVEC-ROKL
DEGARELIX vs DELAVIRDINE
DEGARELIX vs DELORAZEPAM